Algeta schedules first quarter 2013 results presentation, webcast and conference call

Algeta schedules first quarter 2013 results presentation, webcast and 
conference call 
OSLO, NORWAY -- (Marketwired) -- 05/07/13 --  Algeta ASA (OSE:
ALGETA), a company focused on the
development of novel targeted
cancer therapeutics, will announce its first quarter 2013 results on
Wednesday, 15 May 2013. A presentation by Algeta's senior management
team to investors, analysts and the press will take place in
Oslo at
10:00 CET. 
The  presentation  will  also  be  webcast  live  and  can  be 
accessed through where questions can also be submitted
during the presentation. 
The presentation will take place at 10:00 CET at: 
Haakon VIIs gate 1
 0161 Oslo
Algeta's  senior management will  also host an  international
conference call at 14:30 CET/08:30 Eastern Time (US) (details below). 
To  participate in the conference call, please dial the appropriate
number below
five minutes prior to the call: 
US: +1 877 423 0830
 UK: +44 20 7153 9154
 Norway: +47 21 06 61 13 
Sweden: +46 8-506 443 86
 Denmark: +45 32 71 42 62
 Switzerland: +41
44 580 65 22 
Participant pin code: 281404# 
To access the replay, please dial: 
US: +1 877 679 2989
 UK: +44 20 3364 5196
 Norway: +47 23 50 02 03 
Sweden: +46 8-505 564 73 
Conference reference: 346423# 
A   replay   version   of   the  conference  call  will  also  be
available  at 
The  results report and the presentation  will be available at in the Investors section from 07:00 CET. 
About Algeta 
Algeta is a company focused on developing novel targeted therapies
for patients
with cancer based on its alpha-pharmaceutical platform.
The Company is headquartered in Oslo, Norway, and has a US
subsidiary, Algeta US, LLC, based in Cambridge, MA performing
commercial marketing operations in the US. Algeta is
listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information
Press release: 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
(i) the releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and     
originality of the information contained therein. 
Source: Algeta ASA via Thomson Reuters ONE 
For further information, please contact:
Mike Booth / Renate Birkeli
Communications & Corporate Affairs
+47 23 00 67 32 
Media enquiries:
Mark Swallow
Citigate Dewe Rogerson
+44 207 638 9571 
Knut Ekern
Gambit Hill & Knowlton
+47 22 04 82 00 
Kari Watson
MacDougall Biomedical Communications
+1 781 235 3060 
US investor enquiries:
Tricia Swanson
The Trout Group
+1 646 378 2953
Press spacebar to pause and continue. Press esc to stop.